Seeking Alpha (registration) Azithromycin is currently the leading macrolide (type/class of antibiotic) on the market, and approximately fills 51 mil. prescriptions per year in the U.S. Although the drug is quite efficient, bacterial resistance has reduced some efficiency, which ... and more »
Boston Business Journal (blog) Miller said the timing of the company's formation has to do with the development of a new process to create antibiotics – created by Macrolide co-founder and Harvard Professor Andrew Myers. Previously, the antibiotic could only be engineered within ...
Xconomy Macrolide Pharmaceuticals, LLC. is a new anti-infective company founded to advance groundbreaking technology developed by Professor Andrew Myers of Harvard University. Website http://www.macrolidepharma.com; Transaction Type Venture Equity ...
Xconomy Newton, MA-based Macrolide has raised a $22 million Series A round from the venture arms of GlaxoSmithKline (SR One), Novartis (Novartis Venture Fund) and Roch...
pharmabiz.com Tianyin Pharmaceutical, a pharmaceutical company that specialises in the development and sale of patented biopharmaceutical medicine, modernised TCM, branded generics and API, updated on the business and development at its Jiangchuan Macrolide ...
OncLive Eribulin is a synthetic analog of halichondrin B, a polyether macrolide derived from the marine sponge Halichondria okadai. The agent inhibits the assembly of microtubules by binding to the tubulin vinca domain, causing cell cycle arrest. The FDA ... and more »
HCPLive Community-acquired pneumonia presents a number of dilemmas. Patients may be elderly or frail and it's sometimes difficult to identify the infectious organism initially. There is considerable debate about the selection of an appropriate antibiotic or ...
Healio “Widespread use of 1g azithromycin for M. genitalium has been associated with emergence of macrolide resistance and declining cure rates in some settings,” researchers wrote in Clinical Infectious Diseases. “Moxifloxacin has been shown to be effective ...
PR Newswire (press release) Omeclamox-Pak is contraindicated in patients with a history of hypersensitivity to omeprazole, any macrolide antibiotic or penicillin. The safety and effectiveness of Omeclamox-Pak in the pediatric population has not yet been established. Omeclamox-Pak ... and more »
